Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07836153

Mechanical Power and Mortality in Mechanically Ventilated Adults

This prospective observational cohort study aims to investigate the relationship between mechanical power during the first 72 hours of invasive mechanical ventilation and 28-day mortality in mechanically ventilated adult patients admitted to the Surgical Intensive Care Unit at Zagazig University Hospitals.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Surgical Intensive Care Unit, Zagazig University Hospitals

Zagazig, Sharqia Province, Egypt

About this study

This prospective observational cohort study will enroll adult patients admitted to the Surgical Intensive Care Unit who require invasive mechanical ventilation. Mechanical power will be calculated during the first 72 hours of invasive mechanical ventilation using ventilatory parameters recorded during routine clinical care. Patient demographic and clinical characteristics, respiratory and ventilatory parameters, and relevant laboratory data will be recorded. Patients will be followed during their ICU stay, and 28-day mortality will be assessed as the primary outcome. The association between mechanical power and 28-day mortality will be evaluated using appropriate statistical analyses, including receiver operating characteristic (ROC) curve analysis to assess the predictive performance of mechanical power.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years.
  • Both sexes.
  • Patients requiring invasive controlled mechanical ventilation in the ICU and expected to require mechanical ventilation for at least 72 hours.
  • Enrollment within the first 8 hours after initiation of invasive mechanical ventilation.
  • Acceptance and written informed consent from a first-degree relative.

Exclusion criteria

  • Predominant spontaneous breathing or weaning modes during the first 48 hours.
  • Severe hemodynamic instability precluding standardized measurements.
  • Prolonged mechanical ventilation prior to ICU admission.
  • Pregnancy.
  • Chest trauma.

Treatment and study plan

Primary outcomes

  1. 28-Day Mortality

    Time frame: At 28 days after initiation of invasive mechanical ventilation

    All-cause mortality within 28 days after initiation of invasive mechanical ventilation.

Secondary outcomes

  1. Driving Pressure and Plateau Pressure

    Time frame: At 24, 48, and 72 hours after initiation of invasive mechanical ventilation

    Correlation between mechanical power and driving pressure and plateau pressure at 24, 48, and 72 hours.

  2. Ventilator-Free Days

    Time frame: Through 28 days after initiation of invasive mechanical ventilation

    Number of ventilator-free days within the first 28 days.

  3. ICU Length of Stay

    Time frame: From ICU admission until ICU discharge or death, through 28 days after initiation of invasive mechanical ventilation

    Duration of stay in the intensive care unit

Interested in participating?

Not yet recruiting

Trial opening soon.

Get Notified

Sponsors and collaborators

Lead sponsor

Zagazig University

Other Gov

Registry information

Official study title

Relation Between Mechanical Power and Mortality in Mechanically Ventilated Adult Patients

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 23, 2026
Registry last updated
Sep 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.